Skip to main content

93 7219 Pill - yellow capsule/oblong, 14mm

Pill with imprint 93 7219 is Yellow, Capsule/Oblong and has been identified as Topiramate 100 mg. It is supplied by Teva Pharmaceuticals USA.

Topiramate is used in the treatment of Migraine Prevention; Lennox-Gastaut Syndrome; Seizure Prevention; Epilepsy; Seizures and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 93 7219

Topiramate 100 mg 93 7219
Topiramate 100 mg 93 7219
Topiramate 100 mg 93 7219


93 7219
100 mg
14.00 mm
Prescription only
Drug Class
Carbonic anhydrase inhibitor anticonvulsants
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA
Inactive Ingredients
silicon dioxide, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol 4000, corn starch, sodium starch glycolate type A potato, titanium dioxide, hypromellose 2910 (15 mPa.s), polydextrose, ferric oxide yellow, ferrosoferric oxide

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00093-7219 (Discontinued) Teva Pharmaceuticals USA, Inc.
68071-0813 Nucare Pharmaceuticals Inc. (repackager)

Get help with Imprint Code FAQs.

Related images for "93 7219"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.